ER-POSITIVE BREAST CANCER

Refine Results:
All Categories Epidemiology and Etiology (29) Prevention and Screening (10) Diagnosis and Staging (27) Treatment (85) Supportive Oncology (4)

CME

Postmenpausal Woman With Metastatic Breast Cancer And Ongoing Treatment
An interactive CME program provided by RealCME
OncologySTAT CME
Treating the HER2-Positive Breast Cancer Patient
OncologySTAT CME
Postmenopausal Woman With Suspected Metastatic Breast Cancer
An interactive CME program provided by RealCME
OncologySTAT CME
A 67-Year-Old Woman With a Recently Identified, Palpable Left Breast Mass
An interactive, case-based CME program provided by MedCases
OncologySTAT CME

News

FDA Approves Lapatinib-Letrozole Combination for Advanced Breast Cancer
Elsevier Global Medical News, 2010 Feb 1, E Mechcatie
Risk of Breast Cancer Death Higher in Patients on Paroxetine and Tamoxifen
Elsevier Global Medical News, 2010 Jan 12, B Bates
Early Look at Ki67 May ID Nonresponders to Neoadjuvant Estrogen Therapy
Elsevier Global Medical News, 2010 Jan 6, B Bates
Switching Aromatase Inhibitors Often Improves Musculoskeletal Symptoms
Elsevier Global Medical News, 2009 Dec 30, B Jancin
TEAM Trial: 5 Years of Aromatase Inhibitor Equal to Sequential Therapy
Elsevier Global Medical News, 2009 Dec 30, B Jancin
More News ›

Journal Scans

Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer
J Clin Oncol, 2010 Aug 9, WF Symmans, et al
Predictors of Recurrence in Breast Cancer Patients With a Pathologic Complete Response After Neoadjuvant Chemotherapy
Br J Cancer, 2010 Jul 27, M Tanioka, et al
Factor V Leiden Mutation and Thromboembolism Risk in Women Receiving Adjuvant Tamoxifen for Breast Cancer
J Natl Cancer Inst, 2010 Jul 7, JE Garber, et al
Early Discontinuation and Nonadherence to Adjuvant Hormonal Therapy in a Cohort of 8,769 Early-Stage Breast Cancer Patients
J Clin Oncol, 2010 Jun 28, DL Hershman, et al
EXPERT COMMENTARY
Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women
J Clin Oncol, 2010 Jun 21, RT Chlebowski, et al
More Journal Scans ›

Review Articles

Genistein and hematological malignancies
Cancer Lett, 2010 Oct 1, Wang Li, et al
Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer
Crit Rev Oncol Hematol, 2010 Sept 1, David J. Stewart
Tumour markers predictive of successful treatment of breast cancer with primary endocrine therapy in patients over 70 years old: A prospective study
Crit Rev Oncol Hematol, 2010 Sept 1, Anne Stotter, et al
Chronic Hepatitis B and Hepatocellular Carcinoma
Clin Liver Dis, 2010 Aug 1, Amy C. McClune, et al
Cancer diagnosis in people with severe mental illness: practical and ethical issues
Lancet Oncol, 2010 Aug 1, Louise M Howard, et al
More Review Articles ›

All Journals

Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer
Hum Pathol, 2010 Jun 1, Julie M. Wu, et al
Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer
Cancer Lett, 2010 Jun 1, Christina Bendrik, et al
Implication of microRNAs in drug resistance for designing novel cancer therapy
Drug Resist Updat, 2010 Jun 1, Fazlul H. Sarkar, et al
Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism
Lancet Oncol, 2010 Jun 1, Mary V Relling, et al
Differences in prognostic factors and patterns of failure between invasive micropapillary carcinoma and invasive ductal carcinoma of the breast: Matched case–control study
Breast, 2010 Jun 1, Jeong Il Yu, et al
More All Journals ›

Viewpoints

The 2009 San Antonio Breast Cancer Symposium: Potentially Practice-Changing Studies, Part II
2010 Feb 18, Lee Schwartzberg, et al
The 2009 San Antonio Breast Cancer Symposium: Potentially Practice-Changing Studies
2010 Jan 25, Lee Schwartzberg, et al
2009 ASCO Annual Meeting: The Best in Breast Cancer
2009 Jul 28, Lee Schwartzberg, et al
Interview With Drs. Lee Schwartzberg and David Henry Part 2
Linda Bosserman for the OncologySTAT Editorial Team, 2008 Feb 14
Should Anthracyclines Still Be Regarded as the Cornerstone of Adjuvant Breast Cancer Therapy?
2008 Jan 7, Jame Abraham, et al
More Viewpoints ›

Chemotherapy Regimens

Hormone therapy (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Trastuzumab, vinorelbine (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TH (paclitaxel, trastuzumab [Herceptin])
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
TC (docetaxel, cyclophosphamide) (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
Paclitaxel (Breast)
The Elsevier Guide to Oncology Drugs & Regimens (2008 edition)
More Chemotherapy Regimens ›

Videos

Adjuvant AIs vs Tamoxifen
Elsevier Global Medical News, 2008 Dec 11, K Wachter
TEAM Trial: Exemestane vs Tamoxifen
Elsevier Global Medical News, 2008 Dec 11, K Wachter

OncologySTAT Mobile

Away from the office, hospital or computer? Put the power of Elsevier's vast oncology resources in your pocket!

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
    • Forgot your password?
    Not a member? Free registration